Product Information
PYRIMETHAMINE 25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $137.0088 per EA under NDC 00480372001. Its NADAC has been published 36 times since Oct 22, 2025.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480372001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
PYRIMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA215506On Market Since
12/15/2021
Pharmacological Classes
Price Statistics
The NADAC for PYRIMETHAMINE 25 MG TABLET has been published 36 times since Oct 22, 2025, and over the history we have for it it has declined 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $137.0088 per EA |
|---|---|
| All-time high | $152.2259 (Dec 10, 2025) |
| All-time low | $137.0088 (Mar 18, 2026) |
| 52-week high | $152.2259 |
| 52-week low | $137.0088 |
| Median price | $143.1404 |
| Average price | $143.9506 |
| Largest weekly change | -4.3% (Mar 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PYRIMETHAMINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PYRIMETHAMINE 25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $137.0088 per EA (NDC 00480372001), effective Jun 24, 2026.
How has the price of PYRIMETHAMINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PYRIMETHAMINE 25 MG TABLET has declined 10.0%. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for PYRIMETHAMINE 25 MG TABLET?
Since Oct 22, 2025, the NADAC for PYRIMETHAMINE 25 MG TABLET has ranged from a low of $137.0088 (Mar 18, 2026) to a high of $152.2259 (Dec 10, 2025), with a median of $143.1404 per EA.
Are there cheaper alternatives to PYRIMETHAMINE 25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as PYRIMETHAMINE 25 MG TABLET, but none are currently priced below it.
Who manufactures PYRIMETHAMINE 25 MG TABLET?
PYRIMETHAMINE 25 MG TABLET (NDC 00480372001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification